Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study - Matulonis, UA; Lorusso, D; Oaknin, A (J Clin Oncol, 2023)